BIOCHEMICAL AND PHARMACOLOGIC RATIONALE FOR THE DEVELOPMENT OF A SYNTHETIC HEPARIN PENTASACCHARIDE
- 1 April 1997
- journal article
- review article
- Published by Elsevier in Thrombosis Research
- Vol. 86 (1), 1-36
- https://doi.org/10.1016/s0049-3848(97)00042-x
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Anticoagulant Actions of Tissue Factor Pathway Inhibitor on Tissue-Factor-Dependent Plasma CoagulationSeminars in Thrombosis and Hemostasis, 1995
- Synthetic Analogues of the Antithrombin III– Binding Pentasaccharide Sequence of HeparinArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Inhibition of factor X and factor V activation by dermatan sulfate and a pentasaccharide with high affinity for antithrombin III in human plasmaEuropean Journal of Biochemistry, 1990
- New carbohydrate site in mutant antithrombin (7 Ile→Asn) with decreased heparin affinityFEBS Letters, 1988
- Proposed heparin binding site in antithrombin based on arginine 47. A new variant Rouen-II, 47 Arg to Ser.JCI Insight, 1988
- Mono- and bidimensional 500 MHz 1H-NMR spectra of a synthetic pentasaccharide corresponding to the binding sequence of heparin to antithrombin-III: Evidence for conformational peculiarity of the sulfated iduronate residueBiochemical and Biophysical Research Communications, 1985
- Preliminary Biochemical and Pharmacologic Studies on a Chemically Synthesized PentasaccharideSeminars in Thrombosis and Hemostasis, 1985
- Effect of Heparin and Heparin Fractions on Platelet AggregationJCI Insight, 1980
- Anticoagulant activity of heparin: Separation of high‐activity and low‐activity heparin species by affinity chromatography on immobilized antithrombinFEBS Letters, 1976
- The separation of active and inactive forms of heparinBiochemical and Biophysical Research Communications, 1976